Upgrade to SI Premium - Free Trial

Credit Suisse Downgrades Abbvie (ABBV) to Neutral; Path to Upside Difficult

October 31, 2016 7:13 AM
Credit Suisse downgraded Abbvie (NYSE: ABBV) from Outperform to Neutral with a price target of $60.00 (from $70.00), saying while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Downgrades

Next Articles